MK-677 (Ibutamoren): Reference Overview and Reconstitution Notes

MK-677 (Ibutamoren) is a small, man-made molecule that can be taken by mouth. It belongs to a group called growth-hormone secretagogues (compounds that prompt the body to release growth hormone). It is studied in metabolic and growth-hormone research. It is not FDA-approved and is for research use only.

MK-677 (Ibutamoren)

What it is

MK-677, also known as Ibutamoren, is a small, man-made molecule that can be taken by mouth. It belongs to a chemical family called spiroindolines. It works as a growth-hormone secretagogue (a compound that signals the body to release more growth hormone) and as a ghrelin mimetic (something that copies the action of ghrelin, a natural hormone linked to hunger and growth). It does this by latching onto the growth-hormone secretagogue receptor (GHSR-1a), the same docking site in the body that ghrelin naturally attaches to.

Key point: MK-677 is a growth-hormone secretagogue that can be taken by mouth and is strictly limited to research settings.

Research context and categorization

MK-677 is grouped with growth-hormone secretagogues. These fall under the broader category of metabolic and growth-hormone research. Because it is not a peptide (peptides are short chains of amino acids, the building blocks of proteins), it is chemically different from injectable peptide secretagogues, even though researchers often discuss it alongside them.

In research, MK-677 is studied in relation to the growth-hormone and insulin-like growth factor 1 (GH/IGF-1) axis. Think of this axis as a communication line that helps control growth and metabolism in the body. MK-677 is reported to raise circulating levels of GH and IGF-1 by acting through the receptor, not by directly replacing those hormones.

It has been studied in research on body composition (the balance of fat, muscle, and bone in the body), lean mass, and bone mineral density (how solid and strong bones are). Studies have included older adults and people at higher risk of losing bone density. Researchers also discuss it in connection with sleep and appetite because of how it acts at the ghrelin receptor.

All of these uses are investigational. MK-677 has not completed the trials needed for approval, and none of the outcomes above are confirmed or approved benefits. They are research and discussion context only, not established results.

Status

• Regulatory status: Research-only, not FDA-approved. MK-677 reached mid-stage (Phase II) clinical testing for conditions such as growth-hormone deficiency, muscle wasting, and osteoporosis (a condition where bones become weak and brittle), but commercial development was stopped. It has never been approved for any human use and is treated as an investigational compound.
• Sport status: Prohibited under the WADA (World Anti-Doping Agency) Prohibited List. It is classified within class S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), specifically as a growth-hormone secretagogue, and is banned both in-competition and out-of-competition.

Reconstitution notes (general)

For lyophilized (freeze-dried) research powders that are mixed back into liquid, the working concentration equals the milligrams of powder in the vial divided by the milliliters of bacteriostatic water added. For example, 10 mg in 1 mL gives a concentration of 10 mg/mL. A reconstitution calculator is available at peptide calculator.

Dilution and handling notes (compound-specific)

MK-677 is not a lyophilized peptide, so the standard bacteriostatic-water reconstitution process does not apply to it. It is an orally active small molecule. It typically comes as capsules or a ready-to-use liquid solution, with a common solution concentration of around 25 mg/mL.

Solubility and Solvents

MK-677 does not dissolve well in plain water. Think of it like trying to mix oil and water. It just does not blend easily on its own. That is why finished liquid products are usually prepared in a solvent system rather than water alone. When a lab starts from raw powder, common solvents include DMSO, ethanol, or PEG-400. These liquids dissolve MK-677 far more easily than water does.

If a water-based preparation is tried at higher concentrations, the compound may not fully dissolve. The solution can turn cloudy or leave visible particles at the bottom. Using the right solvent and mixing thoroughly are the practical fixes. Because MK-677 is handled as an oral-form reagent at the lab bench, there are no reconstitution-for-injection steps to follow.

Handling and storage

• Store finished solutions in the refrigerator at 2 to 8 C and keep them away from direct light.
• Wipe any bottle or vial closure with an alcohol pad before accessing it, and label the container with the preparation or mix date.
• As a general guideline, a refrigerated working solution is often used within roughly a four-week window.
• Discard any material that becomes cloudy, changes color, or shows floating particles or sediment.

Related reading

• MOTS-c
• N-Acetyl Epitalon Amidate
• NAD+ (Nicotinamide Adenine Dinucleotide)
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is MK-677 and how does it work?

MK-677 is a spiroindoline growth-hormone secretagogue that acts on the GHSR-1a receptor to stimulate GH and IGF-1 release, functioning as a ghrelin mimetic.

What is the regulatory status of MK-677?

MK-677 is research-only, not FDA-approved, reached Phase II trials but development was stopped, and is WADA prohibited in competition.

How do you calculate concentration when reconstituting lyophilized research powders?

Concentration equals milligrams of powder divided by milliliters of bacteriostatic water added; for example, 10 mg in 1 mL yields 10 mg/mL.

What the research community gets wrong about MK-677 (Ibutamoren)

• It is not a peptide, so it does not reconstitute like one. MK-677 is a small spiroindoline molecule, not a short chain of amino acids. Adding bacteriostatic water to it the way you would for a lyophilized peptide vial does not give you a clean working solution.
• Haze in plain water is not always a bad batch. MK-677 dissolves poorly in water alone. Cloudiness or particles at higher concentrations at the bench often point to the wrong solvent, not a degraded sample. Labs typically use a solvent system (for example DMSO, ethanol, or PEG-400) rather than water.
• There are no reconstitution-for-injection steps here. This is handled as an orally active reagent at the bench. Treating the vial like an injectable prep adds steps that simply do not apply.
• "Growth-hormone secretagogue" does not mean the vial contains growth hormone. It is a receptor-acting compound studied in relation to the GH/IGF-1 axis. It does not carry or replace any hormone on its own.
• Reaching Phase II is not the same as being approved. MK-677 was tested in mid-stage trials, development was stopped, and it was never approved for any use. Being widely discussed in the literature does not change its research-only status.

From our bench: If you have prepared MK-677 as a stock solution, we want to hear what actually happened at your hood. Which solvent did you reach for first, at what target concentration did the solution stay clear versus turn hazy, and how long did a refrigerated aliquot hold its appearance before you noticed any sediment? Share your own recorded numbers and we will add tested bench notes here instead of estimates.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. Ibutamoren (MK-677), PubChem CID 178024 , U.S. National Library of Medicine
5. Nass R, et al. Effects of an oral ghrelin mimetic (MK-677) on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008. PMID 18981485
6. Copinschi G, et al. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology. 1997. PMID 9349662